Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Aster DM Healthcare Limited (ASTERDM.BO)
INR825.05
+12.30 (+1.51%)
AE BSE Healthcare Medical - Care Facilities
Address
Tower D - Aspect Tower
Dubai, AE
Dubai, AE
CEO
N. Prashanth
Website
asterdmhealthcare.com
IPO
2018-02-22
ISIN INE914M01019
Also trades on
Bombay Stock Exchange · ASTERDM.BO (INR)
National Stock Exchange of India · ASTERDM.NS (INR)
Description
Aster DM Healthcare Limited provides a broad spectrum of healthcare and associated services throughout various regions, including India, the United Arab Emirates, Qatar, Oman, the Kingdom of Saudi Arabia, Jordan, Kuwait, Bahrain, and the Republic of Mauritius. The company organizes its operations across key segments: Hospitals, Clinics, Retail Pharmacies, and other related ventures. Its facilities include hospitals with integrated in-house pharmacies, as well as clinics that also house pharmacies. Beyond these, it manages a network of retail pharmacies and optical outlets. Moreover, Aster DM Healthcare extends its offerings to include healthcare consultancy and other professional services. Founded in 1987, the enterprise maintains its headquarters in Dubai, United Arab Emirates.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
INR825.05
+12.30 (+1.51%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
134.8K
Beta
-0.04
Float Shares
242.40M
Free Float %
46.9%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.18% | -1.30% | +7.33% | +21.18% | +7.30% | +18.64% | +33.39% | +188.86% | +368.50% | +284.79% | +284.79% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
825.05
DCF (Unlevered)
10.78
-98.7%
DCF (Levered)
335.40
-59.3%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 4 | 0 |
| Buy | 6 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
7.67
Safe zone
Piotroski F-Score
2 / 9
Weak
MOAT Score
7 / 10
Strong MOAT
Composite Rating
B-
Overall Score
3 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
4 / 5
High
ROA Score
4 / 5
High
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Care Facilities: +10.2%+14.1% ★ Q1'26: +27.0% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%-93.0% Q1'26: +71.5% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+6.0% ★ Q1'26: +7.4% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%+13.7% ★ Q1'26: +14.0% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%+8.3% ★ Q1'26: +10.9% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%+3.5% Q1'26: +3.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×2.46× ★ Q1'26: 2.39× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 9 Rev. Ana. 9 EPS Ana. |
Mar 2027 4 Rev. Ana. 4 EPS Ana. |
Mar 2028 4 Rev. Ana. 4 EPS Ana. |
Mar 2029 3 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
66.23B
est: 67.21B (-1.5%)
|
78.00B
est: 79.72B (-2.2%)
|
84.51B
est: 87.69B (-3.6%)
|
85.23B
est: 87.99B (-3.1%)
|
102.53B
est: 102.01B (+0.5%)
|
29.52B
est: 119.37B (-75.3%)
|
36.38B
est: 140.33B (-74.1%)
|
40.69B
est: 42.31B (-3.8%)
|
46.26B
45.67B – 47.92B
+9.3% YoY
|
57.26B
53.20B – 59.41B
+23.8% YoY
|
69.81B
67.29B – 71.88B
+21.9% YoY
|
94.26B
89.38B – 97.39B
+35.0% YoY
|
| EBITDA |
7.78B
est: 8.92B (-12.8%)
|
8.76B
est: 10.58B (-17.2%)
|
12.30B
est: 11.64B (+5.7%)
|
11.15B
est: 11.68B (-4.5%)
|
15.34B
est: 13.54B (+13.4%)
|
4.73B
est: 15.84B (-70.2%)
|
5.87B
est: 18.62B (-68.5%)
|
8.27B
est: 7.35B (+12.6%)
|
8.04B
7.93B – 8.32B
+9.3% YoY
|
9.95B
9.24B – 10.32B
+23.8% YoY
|
12.13B
11.69B – 12.49B
+21.9% YoY
|
16.38B
15.53B – 16.92B
+35.0% YoY
|
| EBIT |
4.80B
est: 5.94B (-19.1%)
|
5.69B
est: 7.04B (-19.2%)
|
6.44B
est: 7.75B (-16.9%)
|
4.97B
est: 7.78B (-36.1%)
|
8.94B
est: 9.01B (-0.8%)
|
2.81B
est: 10.55B (-73.4%)
|
3.67B
est: 12.40B (-70.4%)
|
5.79B
est: 4.76B (+21.6%)
|
5.20B
5.14B – 5.39B
+9.3% YoY
|
6.44B
5.99B – 6.68B
+23.8% YoY
|
7.85B
7.57B – 8.09B
+21.9% YoY
|
10.61B
10.06B – 10.96B
+35.0% YoY
|
| Net Income |
2.69B
est: 1.60B (+68.3%)
|
3.33B
est: 2.21B (+50.6%)
|
2.77B
est: 2.32B (+19.1%)
|
1.48B
est: 1.16B (+27.2%)
|
5.26B
est: 3.93B (+33.8%)
|
4.25B
est: 3.25B (+30.6%)
|
1.29B
est: 3.38B (-61.7%)
|
53.78B
est: 3.37B (+1,495.9%)
|
3.62B
3.20B – 4.11B
+7.4% YoY
|
6.29B
4.97B – 7.73B
+73.8% YoY
|
8.41B
7.60B – 10.32B
+33.7% YoY
|
9.03B
8.42B – 9.42B
+7.3% YoY
|
| SGA |
4.22B
est: 13.20B (-68.0%)
|
4.34B
est: 15.66B (-72.3%)
|
8.83B
est: 17.22B (-48.7%)
|
8.04B
est: 17.28B (-53.5%)
|
10.73B
est: 20.03B (-46.5%)
|
7.55B
est: 23.44B (-67.8%)
|
9.83B
est: 27.56B (-64.3%)
|
11.00B
est: 9.06B (+21.5%)
|
9.90B
9.78B – 10.26B
+9.3% YoY
|
12.26B
11.39B – 12.72B
+23.8% YoY
|
14.94B
14.40B – 15.39B
+21.9% YoY
|
20.18B
19.13B – 20.85B
+35.0% YoY
|
| EPS |
5.75
est: 3.20 (+79.4%)
|
6.63
est: 4.44 (+49.5%)
|
5.51
est: 4.66 (+18.3%)
|
2.97
est: 2.33 (+27.5%)
|
10.58
est: 7.89 (+34.2%)
|
8.54
est: 6.52 (+30.9%)
|
2.60
est: 6.77 (-61.6%)
|
107.99
est: 6.53 (+1,554.1%)
|
7.01
6.21 – 7.97
+7.4% YoY
|
12.18
9.63 – 14.98
+73.8% YoY
|
16.29
14.73 – 19.99
+33.7% YoY
|
17.49
16.31 – 18.24
+7.3% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | B- | 3/5 | 3/5 | 4/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-11 | B- | 3/5 | 3/5 | 4/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-08 | B- | 2/5 | 3/5 | 3/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-07 | B- | 2/5 | 3/5 | 3/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-06 | B- | 2/5 | 3/5 | 3/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-05 | B- | 2/5 | 3/5 | 3/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-04 | B- | 2/5 | 3/5 | 3/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-32.67B
OE per share TTM
-65.67
Owner's Yield
-8.65%
Maintenance CapEx ratio
66.49%
Maint CapEx / Avg PPE
74.8%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 58 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares MSCI India Small-Cap ETF SMIN | 0.55% | 4.00M | 0.74% |
| 2 | State Street SPDR MSCI Emerging Markets Small Cap UCITS ETF EMSD.L | 0.12% | 743.2K | 0.55% |
| 3 | iShares MSCI Emerging Markets Small-Cap ETF EEMS | 0.12% | 442.0K | 0.72% |
| 4 | iShares MSCI EM Small Cap UCITS ETF IEMS.L | 0.11% | 398.5K | 0.74% |
| 5 | Avantis Responsible Emerging Markets Equity ETF AVSE | 0.08% | 185.7K | 0.33% |
| 6 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.04% | 6.43M | 0.06% |
| 7 | Avantis Emerging Markets Small Cap Equity ETF AVEE | 0.04% | 47.7K | 0.42% |
| 8 | Avantis Emerging Markets ex-China Equity ETF AVXC | 0.04% | 160.3K | 0.33% |
| 9 | Dimensional - Emerging Markets ex China Core Equity ETF DEXC | 0.04% | 120.2K | 0.56% |
| 10 | Avantis Emerging Markets Equity ETF AVEM | 0.02% | 6.35M | 0.33% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
454.3K
Shares Outstanding
516.94M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Mandayapurath Azad Moopen DTCD MBBS | Founder, MD & Executive Chairman | 95M | — |
| Alisha Moopen | Deputy MD & Executive Director | 3M | female |
| Hitesh Dhaddha | Chief of Investor Relations and Merger & Amalgamation | — | male |
| Jake Barnard | Group General Counsel | — | male |
| N. Prashanth | Chief Executive Officer of Karnataka Cluster | — | — |
| S. Ramesh Kumar | Group Chief Operating Officer | — | male |
| Sudeep Dey | Chief Information & Information Security Officer | — | male |
| Sunil Kumar R. | Chief Financial Officer | — | male |
| Thadathil Joseph Wilson | Group Head of Governance & Corporate Affairs and Non-Executive Non-Independent Director | — | male |
| Hemish Purushottam | Company Secretary & Compliance Officer | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ASTERDM.BO
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
